BONEVIEW software from French company Gleamer is capable of detecting fractures and reducing the rate of diagnostic errors, thanks to the use of artificial intelligence. Already in use in a dozen countries, including France, the program has just received approval from the Food and Drug Administration to be marketed in the United States.
© New Straits Times Press (M) Bhd
Click here to read the full article.
Source: 